STATE AID: COMMISSION APPROVES €40 MILLION ITALIAN AID MEASURE TO SUPPORT CORONAVIRUS RELATED RESEARCH AND DEVELOPMENT ACTIVITIES

 Italy notified to the Commission under the Temporary Framework a €40 million aid measure to support   coronavirus related R&D activities by ReiThera S.r.l., a medium-sized biotechnology company located in   the Lazio region. The public support will take the form of a direct grant.

 The aim of the measure is to support the development of a novel coronavirus vaccine, contributing to   finding solutions to respond to the current health crisis. The candidate vaccine developed by ReiThera   has been evaluated in preclinical studies and in a phase I clinical study that has shown that it is safe in   adult and elderly people. The measure will support the setting-up and implementation of the next   development step, a phase II/III study to confirm safety and demonstrate efficacy.

 For more info click here.